Clinical trial

CESAR Study in Prostate Cancer With Temsirolimus Added to Standard Docetaxel Therapy (CEPTAS)

NCT01206036

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-07-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2010-07-01Date precision: month

Registry last updated2016-01-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostatic Neoplasmsunresolved

Interventions

DocetaxelDRUG · verified · RxNorm: docetaxel

TemsirolimusDRUG · verified · RxNorm: temsirolimus

Sponsors & collaborators

Central European Society for Anticancer Drug Researchlead sponsor

Mapped research locations

EssenGermany1 Freiburg im BreisgauGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01206036 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.